Aignosis
PrivateLast Round
Grant
Feb 13, 2025
Est. Valuation
$1.5M
Total Funding Raised
$144,000
Company Overview
Aignosis is a healthcare technology company that offers an AI-based platform for early autism screening and detection.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aignosis Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Aignosis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 13, 2025 | ||||
| Angel | Jan 24, 2025 |
Aignosis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| WTFund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 26, 2025
Grew 27% QoQ, from 11 to 14 employees.
- Apr 14, 2025
Grew 125% QoQ, from 4 to 9 employees.
Aignosis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aignosis's valuation, stock price, and market status.